RE-BVS – Piemonte Repository

Sfoglia per RIVISTA
BMC CANCER
Collezione AOU Novara

Items : 5

Prolonged 14-day continuous infusion of high-dose ifosfamide for patients with relapsed and refractory high-grade osteosarcoma: a retrospective multicentre cohort study. in BMC cancer / BMC Cancer. 2024 Jun 19;24(1):747. doi: 10.1186/s12885-024-12498-x.

2024
AOU Novara

Tirtei E; Campello A; Sciannameo V; Asaftei SD; Meazza C; Sironi G; Longhi A; Ibrahim T; Tamburini A; Coccoli L; Crocco F; Cagnazzo C; De Luna E; Quarello P; Berchialla P; Fagioli F;

Correction to: Standard (8?weeks) vs long (12?weeks) timing to minimally-invasive surgery after NeoAdjuvant Chemoradiotherapy for rectal cancer: a multicenter randomized controlled parallel group trial (TiMiSNAR). in BMC cancer / BMC Cancer. 2020 Feb 17;20(1):128. doi: 10.1186/s12885-020-6632-y.

2020
AOU Alessandria
AOU Novara

Numico G; Franzone P; Priora F; Fusco V; Rossi M; Traverso E; Ercolani G; Cavaliere D; Solaini L; Torri V; Ceccarelli C; Balestri R; Buccianti P; Baroffio P; Gentilli S; Coratti A; Menegatti B; Perna F; Rosati R; Delpini R; Mammano E; Elmore U; Contardo T; Perinotti R; Morpurgo E; De Nisco C; Pulighe F; Pernazza G; Boni L; et alii...

Standard (8?weeks) vs long (12?weeks) timing to minimally-invasive surgery after NeoAdjuvant Chemoradiotherapy for rectal cancer: a multicenter randomized controlled parallel group trial (TiMiSNAR). in BMC cancer / BMC Cancer. 2019 Dec 16;19(1):1215. doi: 10.1186/s12885-019-6271-3.

2019
AOU Alessandria
AOU Novara

Lymphovascular invasion and extranodal tumour extension are risk indicators of breast cancer related lymphoedema: an observational retrospective study with long-term follow-up. in BMC cancer / BMC Cancer. 2018 Sep 29;18(1):935. doi: 10.1186/s12885-018-4851-2.

2018
AOU Novara

Invernizzi M; Corti C; Lopez G; Michelotti A; Despini L; Gambini D; Lorenzini D; Guerini-Rocco E; Maggi S; Noale M; Fusco N;

FOXA1 and AR in invasive breast cancer: new findings on their co-expression and impact on prognosis in ER-positive patients. in BMC cancer / BMC Cancer. 2018 Jul 3;18(1):703. doi: 10.1186/s12885-018-4624-y.

2018
AOU Città della Salute di Torino
AOU Novara

Castellano I; Sapino A; Cassoni P; Marano F; Ferrando P; Balmativola D; Boldorini R; Metovic J; Rinella L; Catalano MG; Isella C; Annaratone L; Osella-Abate S; Fortunati N; Rangel N;